New study to uncover genetic secrets behind leukemia treatment success
NCT ID NCT07162532
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 30 times
Summary
This study aims to describe the clinical, blood, and genetic characteristics of 45 adults newly diagnosed with chronic lymphocytic leukemia (CLL). Researchers will examine how specific genetic changes, such as IGHV mutation status and del(17p), relate to how well patients respond to treatment. Participants will provide medical history, undergo physical exams, and have blood tests to analyze their genetic profiles. The goal is to better understand which genetic factors influence treatment outcomes like complete remission or disease progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.